![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 05, 2018 1:02:23 PM
A new report that came out on January 10th 2018,about melanoma vaccines key market players still lists AVAX as one them. Here's the link:
http://www.ktre.com/story/37241244/melanoma-global-market-2017-key-players-ab-science-amgen-array-biopharma-avax-technologies-and-more
Why would they include Avax on the list if it's dead for all intents and purposes? I think their strongest points against the big competitors are the statistically high survival rate and almost no side effects. Their weakest is not capitalizing on that. Good doctors and researchers do not always make good business people and it shows.
Just saying, cause otherwise we get nothing from the company.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM